Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

S. Luminari, E. Viel, A.J.M. Ferreri, F. Zaja, E. Chimienti, G. Musuraca, A. Tucci, M. Balzarotti, M. Tani, F. Salvi, E.A. Pesce, A. Ferrari, A.M. Liberati, A. Spadea, D. Marino, M. Bruno-Ventre, S. Volpetti, C. Bottelli, E. Ravaioli, F. MerliM. Spina

Research output: Contribution to journalArticlepeer-review

Original languageItalian
Pages (from-to)68-75
Number of pages8
JournalHematological Oncology
Issue number1
Publication statusPublished - 2018

Cite this